When we get a coronavirus vaccine, thank intellectual property rights

By Chris Butler

Published September 14, 2020 9:52pm ET

When we get a coronavirus vaccine, thank intellectual property rights — Good news in the fight against the novel coronavirus is finally starting to build. Now in trials, AstraZeneca believes it will be able to seek regulatory approval for its vaccine by the end of the year. Also in trials, BioNTech believes the vaccine it is producing with Pfizer could be ready for administration by December. […]

Good news in the fight against the novel coronavirus is finally starting to build.

Now in trials, AstraZeneca believes it will be able to seek regulatory approval for its vaccine by the end of the year. Also in trials, BioNTech believes the vaccine it is producing with Pfizer could be ready for administration by December. Johnson & Johnson has begun human trials of its vaccine and anticipates phase 3 trials by the end of September.